← 產業報告目錄

Organoids Market Research Report Information By Product and Service (Product and Service), By Type of Organoids (Liver, Kidney, Pancreas, Intestine, Heart, and others), By Application (Drug Testing, Developmental Biology, Personalized Medicine, Regenerative Medicine, and Others), By End-Users (Academic and Research Institutes, Pharmaceutical and Biotechnology Company, Contract Research Organizations (CROs), and Others) And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) –Market Forecast Till 2032

出版商 Market Research Future產業別 Healthcare & Life Sciences出版日期 2024-08-10頁數 146報告編號 MRFRHC18757CR

授權報價

Single User Price$4,950 USD
Multi User Licence (up to 10 users)$5,950 USD
Enterprisewide Price (Global Site License)$7,250 USD
洽詢購買 申請 Sample

報告摘要

Organoids Market Research Report Information By Product and Service (Product and Service), By Type of Organoids (Liver, Kidney, Pancreas, Intestine, Heart, and others), By Application (Drug Testing, Developmental Biology, Personalized Medicine, Regenerative Medicine, and Others), By End-Users (Academic and Research Institutes, Pharmaceutical and Biotechnology Company, Contract Research Organizations (CROs), and Others) And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) –Market Forecast Till 2032 Market Overview The Organoids Market was valued at USD 1.39 billion in 2023. The market is expected to expand from USD 1.68 billion in 2024 to USD 9.16 billion by 2032, with a compound annual growth rate (CAGR) of 23.55% over the forecast period (2024-2032). Rising demand for personalized medication, as well as increased use of drug discovery and toxicology research, are driving market expansion. The growing desire for personalized treatment is a significant driver of the Organoids Market's growth. Personalized medicine, often known as precision medicine, focuses on personalizing medical therapy to each patient's unique traits. This method takes into account aspects such as genetics, environment, and lifestyle in order to give more effective and focused treatments. Organoids, which are small 3D tissue constructs that imitate the functions and complexity of organs, have emerged as an important tool for enhancing personalized medicine. Recognizing the significant heterogeneity in how people respond to treatments is an important part of customized medicine. Traditional techniques to drug discovery frequently rely on animal models or 2D cell cultures, which do not truly reflect human biology. Organoids provide a more physiologically appropriate platform for researching disease processes and evaluating medication responses. Researchers can use patient-derived organoids to better understand the specific characteristics of diseases and anticipate how individuals will respond to various therapies. Market Segment insights The Organoids Market is split into product and service. The Organoids Market is divided into six categories: liver, kidney, pancreas, intestine, heart, and others. The market is divided into five applications: drug testing, developmental biology, personalized medicine, regenerative medicine, and others. End-users in the Market include academic and research institutions, pharmaceutical and biotechnology companies, contract research organizations (CROs), and others. Regional insights The Organoids Market has been classified by region: North America, Europe, Asia-Pacific, and the Rest of the World. North America had the biggest market share in 2023 and is expected to reach USD 3.42 billion by 2032, representing a CAGR of 22.88% over the forecast period. The increased use of organoid-based research models in the biotechnology sector in the United States and Canada is due to technological breakthroughs that have permitted the fabrication of 3D organoids and spheroids. In the United States, large university research institutions and biotechnology corporations have been at the forefront of developing organoid technology. The Americas area is followed by Europe, which holds the second highest organoids market share. One crucial contributor is Europe's strong research infrastructure and significant investment in life sciences. Countries such as Germany, the United Kingdom, and the Netherlands have world-class research institutions and biotechnology businesses that are at the forefront of organoid research. The organoids market in Asia Pacific is expanding rapidly, owing to a number of causes. Organoids, three-dimensional tiny organs made from stem cells or tissue, have enormous potential in disease modeling, drug development, and regenerative medicine applications. Major Players Major competitors in the Organoids Market include Thermo Fisher Scientific Inc., Inc., Merck KGaA, Corning Incorporated, STEMCELL Technologies, Bio-Techne, Molecular Devices, LLC, and others.
目錄 Table of Contents
TABLE OF CONTENTS 1 EXECUTIVE SUMMARY 2 MARKET INTRODUCTION 2.1 DEFINITION 2.2 SCOPE OF THE STUDY 2.3 RESEARCH OBJECTIVE 2.4 MARKET STRUCTURE 3 RESEARCH METHODOLOGY 3.1 OVERVIEW 3.2 DATA FLOW 3.2.1 Data Mining Process 3.3 PURCHASED DATABASE: 3.4 SECONDARY SOURCES: 3.4.1 Secondary Research data flow: 3.5 PRIMARY RESEARCH: 3.5.1 Primary Research DATA FLOW: 3.5.2 Primary Research: Number of Interviews conducted 3.6 APPROACHES FOR MARKET SIZE ESTIMATION: 3.6.1 Revenue Analysis Approach 3.7 DATA FORECASTING 3.7.1 Data forecasting Type 3.8 DATA MODELING 3.8.1 microeconomic factor analysis: 3.8.2 Data modeling: 3.9 TEAMS AND ANALYST CONTRIBUTION 4 MARKET DYNAMICS 4.1 INTRODUCTION 4.2 DRIVERS 4.2.1 Rising demand for personalized medicine 4.2.2 Growing applications in drug discovery and toxicology studies 4.3 RESTRAINTS 4.3.1 Regulatory challenges impacting market growth 4.3.2 High cost of development and maintenance 4.4 OPPORTUNITY 4.4.1 Technological advancements enhancing organoid production and applications 4.5 TREND 4.5.1 Rising investment in regenerative medicine 4.5.2 Expanding use in studying developmental biology 4.6 CHALLENGES 4.6.1 Ethical concerns surrounding organoid sourcing and experimentation 4.6.2 Integration challenges with existing medical practices and technologies 4.7 IMPACT ANALYSIS OF COVID-19 4.7.1 Impact on R & D 4.7.2 Impact on Supply Chain 4.7.3 Impact on Pricing 5 MARKET FACTOR ANALYSIS 5.1 VALUE CHAIN ANALYSIS 5.1.1 Raw Material Sourcing and Research & Development (R&D) 5.1.2 Organoid Production and Quality Control/Assurance 5.1.3 Distribution and Logistics 5.1.4 Application in Research, Drug Discovery, and Clinical Translation 5.2 PORTER’S FIVE FORCES MODEL 5.2.1 Threat of New Entrants 5.2.2 Bargaining Power of Suppliers 5.2.3 Threat of Substitutes 5.2.4 Bargaining Power of Buyers 5.2.5 Intensity of Rivalry 6 GLOBAL ORGANOIDS MARKET, BY PRODUCT & SERVICE 6.1 OVERVIEW 7 GLOBAL ORGANOIDS MARKET, BY TYPE OF ORGANOIDS 7.1 OVERVIEW 8 GLOBAL ORGANOIDS MARKET, BY APPLICATION 8.1 OVERVIEW 9 GLOBAL ORGANOIDS MARKET, BY END-USERS 9.1 OVERVIEW 10 GLOBAL ORGANOIDS MARKET, BY REGION 10.1 GLOBAL 10.2 NORTH AMERICA 10.2.1 US 10.2.2 Canada 10.2.3 Mexico 10.3 EUROPE 10.3.1 germany 10.3.2 France 10.3.3 UK 10.3.4 Spain 10.3.5 Italy 10.3.6 Rest of Europe 10.4 ASIA PACIFIC 10.4.1 china 10.4.2 India 10.4.3 Japan 10.4.4 South Korea 10.4.5 Australia 10.4.6 Rest of Asia Pacific 10.5 REST OF THE WORLD 10.5.1 Middle East & Africa 10.5.2 South America 11 COMPETITIVE LANDSCAPE 11.1 COMPETITIVE OVERVIEW 11.2 MAJOR PLAYERS IN THE GLOBAL ORGANOIDS MARKET 11.3 COMPETITIVE BENCHMARKING 11.4 KEY DEVELOPMENTS & GROWTH STRATEGIES 11.4.1 Product launch/development 11.4.2 Contract & Agreement 12 COMPANY PROFILES 12.1 HUB ORGANOIDS 12.1.1 Company Overview 12.1.2 FINANCIAL OVERVIEW 12.1.3 Products/Services Offered 12.1.4 KEY DEVELOPMENTS 12.1.5 SWOT Analysis 12.1.6 Key Strategies 12.2 NEYROBLASTGX 12.2.1 COMPANY OVERVIEW 12.2.2 FINANCIAL OVERVIEW 12.2.3 PRODUCTS OFFERED 12.2.4 KEY DEVELOPMENTS 12.2.5 SWOT ANALYSIS 12.2.6 KEY STRATEGIES 12.3 STEMCELL TECHNOLOGIES 12.3.1 COMPANY OVERVIEW 12.3.2 FINANCIAL OVERVIEW 12.3.3 PRODUCTS OFFERED 12.3.4 KEY DEVELOPMENTS 12.3.5 SWOT ANALYSIS 12.3.6 KEY STRATEGIES 12.4 BIO-TECHNE 12.4.1 COMPANY OVERVIEW 12.4.2 Financial Overview 12.4.3 PRODUCTS OFFERED 12.4.4 Key Developments 12.4.5 SWOT ANALYSIS 12.4.6 KEY STRATEGIES 12.5 THERMO FISHER SCIENTIFIC INC 12.5.1 COMPANY OVERVIEW 12.5.2 Financial Overview 12.5.3 PRODUCTS OFFERED 12.5.4 KEY DEVELOPMENTS 12.5.5 SWOT ANALYSIS 12.5.6 KEY STRATEGIES 12.6 3DNAMICS INC. 12.6.1 COMPANY OVERVIEW 12.6.2 FINANCIAL OVERVIEW 12.6.3 PRODUCTS OFFERED 12.6.4 KEY DEVELOPMENTS 12.6.5 SWOT ANALYSIS 12.6.6 KEY STRATEGIES 12.7 MOLECULAR DEVICES, LLC 12.7.1 Company Overview 12.7.2 FINANCIAL OVERVIEW 12.7.3 Products/Services Offered 12.7.4 Key Developments 12.7.5 SWOT Analysis 12.7.6 Key Strategies 12.8 MERCK KGGA 12.8.1 COMPANY OVERVIEW 12.8.2 Financial Overview 12.8.3 PRODUCTS OFFERED 12.8.4 KEY DEVELOPMENTS 12.8.5 SWOT ANALYSIS 12.8.6 KEY STRATEGIES 12.9 CORNING INCORPORATED 12.9.1 COMPANY OVERVIEW 12.9.2 Financial Overview 12.9.3 PRODUCTS OFFERED 12.9.4 KEY DEVELOPMENTS 12.9.5 SWOT ANALYSIS 12.9.6 KEY STRATEGIES 12.10 CN BIO INNOVATIONS LTD 12.10.1 COMPANY OVERVIEW 12.10.2 FINANCIAL OVERVIEW 12.10.3 PRODUCTS OFFERED 12.10.4 KEY DEVELOPMENTS 12.10.5 SWOT ANALYSIS 12.10.6 KEY STRATEGIES 13 DATA CITATIONS
圖表清單 List of Tables & Figures
LIST OF TABLES TABLE 1 QFD MODELING FOR MARKET SHARE ASSESSMENT TABLE 2 GLOBAL ORGANOIDS MARKET, BY PRODUCT & SERVICE, 2020–2032 (USD MILLION) TABLE 3 GLOBAL ORGANOIDS MARKET, BY TYPE OF ORGANOIDS, 2020–2032 (USD MILLION) TABLE 4 GLOBAL ORGANOIDS MARKET, BY APPLICATION, 2020–2032 (USD MILLION) TABLE 5 GLOBAL ORGANOIDS MARKET, BY END-USERS, 2020–2032 (USD MILLION) TABLE 6 GLOBAL ORGANOIDS MARKET, BY REGION, 2020–2032 (USD MILLION) TABLE 7 NORTH AMERICA: ORGANOIDS MARKET, BY COUNTRY, 2020–2032 (USD MILLION) TABLE 8 NORTH AMERICA ORGANOIDS MARKET, BY PRODUCT & SERVICE, 2020–2032 (USD MILLION) TABLE 9 NORTH AMERICA ORGANOIDS MARKET, BY TYPE OF ORGANOIDS, 2020–2032 (USD MILLION) TABLE 10 NORTH AMERICA ORGANOIDS MARKET, BY APPLICATION, 2020–2032 (USD MILLION) TABLE 11 NORTH AMERICA ORGANOIDS MARKET, BY END-USERS, 2020–2032 (USD MILLION) TABLE 12 US ORGANOIDS MARKET, BY PRODUCT & SERVICE, 2020–2032 (USD MILLION) TABLE 13 US ORGANOIDS MARKET, BY TYPE OF ORGANOIDS, 2020–2032 (USD MILLION) TABLE 14 US ORGANOIDS MARKET, BY APPLICATION, 2020–2032 (USD MILLION) TABLE 15 US ORGANOIDS MARKET, BY END-USERS, 2020–2032 (USD MILLION) TABLE 16 CANADA ORGANOIDS MARKET, BY PRODUCT & SERVICE, 2020–2032 (USD MILLION) TABLE 17 CANADA ORGANOIDS MARKET, BY TYPE OF ORGANOIDS, 2020–2032 (USD MILLION) TABLE 18 CANADA ORGANOIDS MARKET, BY APPLICATION, 2020–2032 (USD MILLION) TABLE 19 CANADA ORGANOIDS MARKET, BY END-USERS, 2020–2032 (USD MILLION) TABLE 20 MEXICO ORGANOIDS MARKET, BY PRODUCT & SERVICE, 2020–2032 (USD MILLION) TABLE 21 MEXICO ORGANOIDS MARKET, BY TYPE OF ORGANOIDS, 2020–2032 (USD MILLION) TABLE 22 MEXICO ORGANOIDS MARKET, BY APPLICATION, 2020–2032 (USD MILLION) TABLE 23 MEXICO ORGANOIDS MARKET, BY END-USERS, 2020–2032 (USD MILLION) TABLE 24 EUROPE: ORGANOIDS MARKET, BY COUNTRY, 2020–2032 (USD MILLION) TABLE 25 EUROPE ORGANOIDS MARKET, BY PRODUCT & SERVICE, 2020–2032 (USD MILLION) TABLE 26 EUROPE ORGANOIDS MARKET, BY TYPE OF ORGANOIDS, 2020–2032 (USD MILLION) TABLE 27 EUROPE ORGANOIDS MARKET, BY APPLICATION, 2020–2032 (USD MILLION) TABLE 28 EUROPE ORGANOIDS MARKET, BY END-USERS, 2020–2032 (USD MILLION) TABLE 29 GERMANY ORGANOIDS MARKET, BY PRODUCT & SERVICE, 2020–2032 (USD MILLION) TABLE 30 GERMANY ORGANOIDS MARKET, BY TYPE OF ORGANOIDS, 2020–2032 (USD MILLION) TABLE 31 GERMANY ORGANOIDS MARKET, BY APPLICATION, 2020–2032 (USD MILLION) TABLE 32 GERMANY ORGANOIDS MARKET, BY END-USERS, 2020–2032 (USD MILLION) TABLE 33 FRANCE ORGANOIDS MARKET, BY PRODUCT & SERVICE, 2020–2032 (USD MILLION) TABLE 34 FRANCE ORGANOIDS MARKET, BY TYPE OF ORGANOIDS, 2020–2032 (USD MILLION) TABLE 35 FRANCE ORGANOIDS MARKET, BY APPLICATION, 2020–2032 (USD MILLION) TABLE 36 FRANCE ORGANOIDS MARKET, BY END-USERS, 2020–2032 (USD MILLION) TABLE 37 UK ORGANOIDS MARKET, BY PRODUCT & SERVICE, 2020–2032 (USD MILLION) TABLE 38 UK ORGANOIDS MARKET, BY TYPE OF ORGANOIDS, 2020–2032 (USD MILLION) TABLE 39 UK ORGANOIDS MARKET, BY APPLICATION, 2020–2032 (USD MILLION) TABLE 40 UK ORGANOIDS MARKET, BY END-USERS, 2020–2032 (USD MILLION) TABLE 41 SPAIN ORGANOIDS MARKET, BY PRODUCT & SERVICE, 2020–2032 (USD MILLION) TABLE 42 SPAIN ORGANOIDS MARKET, BY TYPE OF ORGANOIDS, 2020–2032 (USD MILLION) TABLE 43 SPAIN ORGANOIDS MARKET, BY APPLICATION, 2020–2032 (USD MILLION) TABLE 44 SPAIN ORGANOIDS MARKET, BY END-USERS, 2020–2032 (USD MILLION) TABLE 45 ITALY ORGANOIDS MARKET, BY PRODUCT & SERVICE, 2020–2032 (USD MILLION) TABLE 46 ITALY ORGANOIDS MARKET, BY TYPE OF ORGANOIDS, 2020–2032 (USD MILLION) TABLE 47 ITALY ORGANOIDS MARKET, BY APPLICATION, 2020–2032 (USD MILLION) TABLE 48 ITALY ORGANOIDS MARKET, BY END-USERS, 2020–2032 (USD MILLION) TABLE 49 REST OF EUROPE ORGANOIDS MARKET, BY PRODUCT & SERVICE, 2020–2032 (USD MILLION) TABLE 50 REST OF EUROPE ORGANOIDS MARKET, BY TYPE OF ORGANOIDS, 2020–2032 (USD MILLION) TABLE 51 REST OF EUROPE ORGANOIDS MARKET, BY APPLICATION, 2020–2032 (USD MILLION) TABLE 52 REST OF EUROPE ORGANOIDS MARKET, BY END-USERS, 2020–2032 (USD MILLION) TABLE 53 ASIA PACIFIC: ORGANOIDS MARKET, BY COUNTRY, 2020–2032 (USD MILLION) TABLE 54 ASIA PACIFIC ORGANOIDS MARKET, BY PRODUCT & SERVICE, 2020–2032 (USD MILLION) TABLE 55 ASIA PACIFIC ORGANOIDS MARKET, BY TYPE OF ORGANOIDS, 2020–2032 (USD MILLION) TABLE 56 ASIA PACIFIC ORGANOIDS MARKET, BY APPLICATION, 2020–2032 (USD MILLION) TABLE 57 ASIA PACIFIC ORGANOIDS MARKET, BY END-USERS, 2020–2032 (USD MILLION) TABLE 58 CHINA ORGANOIDS MARKET, BY PRODUCT & SERVICE, 2020–2032 (USD MILLION) TABLE 59 CHINA ORGANOIDS MARKET, BY TYPE OF ORGANOIDS, 2020–2032 (USD MILLION) TABLE 60 CHINA ORGANOIDS MARKET, BY APPLICATION, 2020–2032 (USD MILLION) TABLE 61 CHINA ORGANOIDS MARKET, BY END-USERS, 2020–2032 (USD MILLION) TABLE 62 INDIA ORGANOIDS MARKET, BY PRODUCT & SERVICE, 2020–2032 (USD MILLION) TABLE 63 INDIA ORGANOIDS MARKET, BY TYPE OF ORGANOIDS, 2020–2032 (USD MILLION) TABLE 64 INDIA ORGANOIDS MARKET, BY APPLICATION, 2020–2032 (USD MILLION) TABLE 65 INDIA ORGANOIDS MARKET, BY END-USERS, 2020–2032 (USD MILLION) TABLE 66 JAPAN ORGANOIDS MARKET, BY PRODUCT & SERVICE, 2020–2032 (USD MILLION) TABLE 67 JAPAN ORGANOIDS MARKET, BY TYPE OF ORGANOIDS, 2020–2032 (USD MILLION) TABLE 68 JAPAN ORGANOIDS MARKET, BY APPLICATION, 2020–2032 (USD MILLION) TABLE 69 JAPAN ORGANOIDS MARKET, BY END-USERS, 2020–2032 (USD MILLION) TABLE 70 SOUTH KOREA ORGANOIDS MARKET, BY PRODUCT & SERVICE, 2020–2032 (USD MILLION) TABLE 71 SOUTH KOREA ORGANOIDS MARKET, BY TYPE OF ORGANOIDS, 2020–2032 (USD MILLION) TABLE 72 SOUTH KOREA ORGANOIDS MARKET, BY APPLICATION, 2020–2032 (USD MILLION) TABLE 73 SOUTH KOREA ORGANOIDS MARKET, BY END-USERS, 2020–2032 (USD MILLION) TABLE 74 AUSTRALIA ORGANOIDS MARKET, BY PRODUCT & SERVICE, 2020–2032 (USD MILLION) TABLE 75 AUSTRALIA ORGANOIDS MARKET, BY TYPE OF ORGANOIDS, 2020–2032 (USD MILLION) TABLE 76 AUSTRALIA ORGANOIDS MARKET, BY APPLICATION, 2020–2032 (USD MILLION) TABLE 77 AUSTRALIA ORGANOIDS MARKET, BY END-USERS, 2020–2032 (USD MILLION) TABLE 78 REST OF ASIA PACIFIC ORGANOIDS MARKET, BY PRODUCT & SERVICE, 2020–2032 (USD MILLION) TABLE 79 REST OF ASIA PACIFIC ORGANOIDS MARKET, BY TYPE OF ORGANOIDS, 2020–2032 (USD MILLION) TABLE 80 REST OF ASIA PACIFIC ORGANOIDS MARKET, BY APPLICATION, 2020–2032 (USD MILLION) TABLE 81 REST OF ASIA PACIFIC ORGANOIDS MARKET, BY END-USERS, 2020–2032 (USD MILLION) TABLE 82 REST OF THE WORLD: ORGANOIDS MARKET, BY COUNTRY, 2020–2032 (USD MILLION) TABLE 83 REST OF THE WORLD ORGANOIDS MARKET, BY PRODUCT & SERVICE, 2020–2032 (USD MILLION) TABLE 84 REST OF THE WORLD ORGANOIDS MARKET, BY TYPE OF ORGANOIDS, 2020–2032 (USD MILLION) TABLE 85 REST OF THE WORLD ORGANOIDS MARKET, BY APPLICATION, 2020–2032 (USD MILLION) TABLE 86 REST OF THE WORLD ORGANOIDS MARKET, BY END-USERS, 2020–2032 (USD MILLION) TABLE 87 MIDDLE EAST & AFRICA ORGANOIDS MARKET, BY PRODUCT & SERVICE, 2020–2032 (USD MILLION) TABLE 88 MIDDLE EAST & AFRICA ORGANOIDS MARKET, BY TYPE OF ORGANOIDS, 2020–2032 (USD MILLION) TABLE 89 MIDDLE EAST & AFRICA ORGANOIDS MARKET, BY APPLICATION, 2020–2032 (USD MILLION) TABLE 90 MIDDLE EAST & AFRICA ORGANOIDS MARKET, BY END-USERS, 2020–2032 (USD MILLION) TABLE 91 SOUTH AMERICA ORGANOIDS MARKET, BY PRODUCT & SERVICE, 2020–2032 (USD MILLION) TABLE 92 SOUTH AMERICA ORGANOIDS MARKET, BY TYPE OF ORGANOIDS, 2020–2032 (USD MILLION) TABLE 93 SOUTH AMERICA ORGANOIDS MARKET, BY APPLICATION, 2020–2032 (USD MILLION) TABLE 94 SOUTH AMERICA ORGANOIDS MARKET, BY END-USERS, 2020–2032 (USD MILLION) TABLE 95 MAJOR PLAYERS IN THE GLOBAL ORGANOIDS MARKET TABLE 96 PRODUCT LAUNCH/DEVELOPMENT TABLE 97 CONTRACT & AGREEMENT TABLE 98 HUB ORGANOIDS: PRODUCTS/SERVICES OFFERED TABLE 99 NEYROBLASTGX: PRODUCTS OFFERED TABLE 100 STEMCELL TECHNOLOGIES: PRODUCTS OFFERED TABLE 101 STEMCELL TECHNOLOGIES: KEY DEVELOPMENTS TABLE 102 BIO-TECHNE: PRODUCTS OFFERED TABLE 103 BIO-TECHNE: KEY DEVELOPMENTS TABLE 104 THERMO FISHER SCIENTIFIC INC: PRODUCTS OFFERED TABLE 105 3DNAMICS INC.: PRODUCTS OFFERED TABLE 106 MOLECULAR DEVICES, LLC: PRODUCTS/SERVICES OFFERED TABLE 107 MOLECULAR DEVICES, LLC: KEY DEVELOPMENTS TABLE 108 MERCK KGGA: PRODUCTS OFFERED TABLE 109 CORNING INCORPORATED: PRODUCTS OFFERED TABLE 110 CN BIO INNOVATIONS LTD: PRODUCTS OFFERED LIST OF FIGURES FIGURE 1 GLOBAL ORGANOIDS MARKET: EXECUTIVE SUMMARY FIGURE 2 GLOBAL ORGANOIDS MARKET: STRUCTURE FIGURE 3 GLOBAL ORGANOIDS MARKET: MARKET GROWTH FACTOR ANALYSIS (2023-2032) FIGURE 4 VALUE CHAIN ANALYSIS OF THE GLOBAL ORGANOIDS MARKET FIGURE 5 PORTER’S FIVE FORCES ANALYSIS: GLOBAL ORGANOIDS MARKET FIGURE 6 GLOBAL ORGANOIDS MARKET, BY PRODUCT & SERVICE, 2023 & 2032(USD MILLION) FIGURE 7 GLOBAL ORGANOIDS MARKET SHARE (%), BY PRODUCT & SERVICE, 2023 FIGURE 8 GLOBAL ORGANOIDS MARKET, BY TYPE OF ORGANOIDS, 2023 & 2032(USD MILLION) FIGURE 9 GLOBAL ORGANOIDS MARKET SHARE (%), BY TYPE OF ORGANOIDS, 2023 FIGURE 10 GLOBAL ORGANOIDS MARKET, BY APPLICATION, 2023 & 2032(USD MILLION) FIGURE 11 GLOBAL ORGANOIDS MARKET SHARE (%), BY APPLICATION, 2023 FIGURE 12 GLOBAL ORGANOIDS MARKET, BY END-USERS, 2023 & 2032(USD MILLION) FIGURE 13 GLOBAL ORGANOIDS MARKET SHARE (%), BY END-USERS, 2022 FIGURE 14 GLOBAL ORGANOIDS MARKET, BY REGION, 2023 & 2032 (USD MILLION) FIGURE 15 GLOBAL ORGANOIDS MARKET SHARE, BY REGION, 2023 (% SHARE) FIGURE 16 NORTH AMERICA: ORGANOIDS MARKET SHARE, BY COUNTRY, 2023 (% SHARE) FIGURE 17 NORTH AMERICA: ORGANOIDS MARKET, BY COUNTRY, 2023 & 2032 (USD MILLION) FIGURE 18 EUROPE: ORGANOIDS MARKET SHARE, BY COUNTRY, 2023 (% SHARE) FIGURE 19 EUROPE: ORGANOIDS MARKET, BY COUNTRY, 2023 & 2032 (USD MILLION) FIGURE 20 ASIA PACIFIC: ORGANOIDS MARKET SHARE, BY COUNTRY, 2023 (% SHARE) FIGURE 21 ASIA PACIFIC: ORGANOIDS MARKET, BY COUNTRY, 2023 & 2032 (USD MILLION) FIGURE 22 REST OF THE WORLD: ORGANOIDS MARKET SHARE, BY COUNTRY, 2023 (% SHARE) FIGURE 23 REST OF THE WORLD: ORGANOIDS MARKET, BY COUNTRY, 2023 & 2032 (USD MILLION) FIGURE 24 BENCHMARKING OF MAJOR COMPETITORS FIGURE 25 HUB ORGANOIDS: SWOT ANALYSIS FIGURE 26 NEYROBLASTGX: SWOT ANALYSIS FIGURE 27 STEMCELL TECHNOLOGIES: SWOT ANALYSIS FIGURE 28 BIO-TECHNE: FINANCIAL OVERVIEW SNAPSHOT FIGURE 29 BIO-TECHNE: SWOT ANALYSIS FIGURE 30 THERMO FISHER SCIENTIFIC INC.: FINANCIAL OVERVIEW SNAPSHOT FIGURE 31 THERMO FISHER SCIENTIFIC INC: SWOT ANALYSIS FIGURE 32 3DNAMICS INC.: SWOT ANALYSIS FIGURE 33 MOLECULAR DEVICES, LLC: SWOT ANALYSIS FIGURE 34 MERCK KGAA: FINANCIAL OVERVIEW SNAPSHOT FIGURE 35 MERCK KGGA: SWOT ANALYSIS FIGURE 36 CORNING INCORPORATED: FINANCIAL OVERVIEW SNAPSHOT FIGURE 37 CORNING INCORPORATED: SWOT ANALYSIS FIGURE 38 CN BIO INNOVATIONS LTD: SWOT ANALYSIS

提及公司

Thermo Fisher Scientific Inc.Merck KGgACorning IncorporatedSTEMCELL TechnologiesBio-TechneMolecular DevicesLLC

同分類最新報告(醫療與生命科學)

量子訊息有限公司為 Market Research Future 在台灣的授權代理,提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們